• Rachel Dawson named managing director for Precision Health

    Precision Health at the University of Michigan has named Rachel Dawson as managing director. She brings more than eight years of operations and talent management experience, leading operations staff, developing teams, and representing organizations with employers and donors.

  • These surgeons wanted to prescribe fewer opioids. So they developed a guide for all to use

    How many prescription pain pills should a patient receive after breast cancer surgery? Or hernia repair? Or gallbladder removal? A new tool developed at the University of Michigan, now available online for free, details recommendations for 11 common operations, based on pain control and surgical quality research, as well as data and surveys from patients throughout Michigan.

  • U-M launches new Precision Health research initiative

    The University of Michigan has launched a new initiative to harness campus-wide research aimed at finding personalized solutions to improve the health and wellness of individuals and communities.

  • 100,000 Points of Data

    Modern medicine gathers astronomical amounts of information on patients, but has had little sense of how to store, process, or apply it. But now doctors and researchers at the University of Michigan are working across disciplines and in multiple areas of medicine to harness individuals’ stats to develop more precise approaches to care. Hour Detroit looks at precision health research across U-M.

  • Prescription Opioid Use a Concern for Adolescent Surgery Patients

    Persistent prescription opioid use may not only be a problem for adult patients. It’s an issue for teens and young adults, too, a new study suggests. Nearly 5 percent of patients ages 13 to 21 who had common surgical procedures continued to receive opioid prescription refills three to six months after surgery.

  • Precision health pioneer named to MIT Technology Review innovator list

    For using data science to identify hospital patients at risk of contracting an infection they didn’t check in with, Michigan Engineering professor Jenna Wiens has been named to MIT Technology Review’s 2017 list of 35 Innovators Under 35.

  • Comprehensive Sequencing Program Shows Promise of Precision Medicine for Advanced Cancer

    The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors and sequences to a level of detail beyond most commercial tests.